CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 5 of 15

Osteoporosis International

Briefs 161–200 of 576 CurrentRheuma has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Anabolic‐steroid therapy after geriatric proximal femur fracture: a level I evidence systematic review and meta-analysis of bone density, functional recovery, and safety

    Meta-analysisOsteoporosis

  2. Osteoporos Int

    Degenerative scoliosis may trigger higher incidence of adjacent vertebral fractures following percutaneous vertebroplasty: a clinical evidence-based biomechanical research

    Cohort studyOsteoporosis

  3. Osteoporos Int

    Fracture trends in Denmark from 1997 to 2021

    Cohort studyOsteoporosis

  4. Osteoporos Int

    Risk factors for osteoporosis in rheumatoid arthritis patients: a meta-analysis

    Meta-analysisRA

  5. Osteoporos Int

    Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis—a national registry study of 36,864 Swedish lymphoma patients

    Cohort studyOsteoporosis

  6. Osteoporos Int

    Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis

    Cohort studyOsteoporosis

  7. Osteoporos Int

    Prevalence of osteosarcopenia in patients with end-stage knee OA who underwent total knee arthroplasty

    Cohort studyOsteoarthritis

  8. Osteoporos Int

    The prospective association between high-density lipoprotein (HDL) cholesterol and risk of incident fractures in the general population

    Cohort studyOsteoporosis

  9. Osteoporos Int

    Beyond the initial impact: a systematic review of post-traumatic bone loss and its mechanisms

    Meta-analysisOsteoporosis

  10. Osteoporos Int

    Explainable opportunistic osteoporosis screening from chest X-rays: a retrospective comparison of foundation models

    Diagnostic or prognostic studyOsteoporosis

  11. Osteoporos Int

    Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries

    Cohort studyOsteoporosis

  12. Osteoporos Int

    The association of bone density and hip fracture risk among Asian women

    Cohort studyOsteoporosis

  13. Osteoporos Int

    The association of loneliness with bone mineral density, osteoporosis, osteopenia, fall, and sarcopenia among older adults: results from Mr. and Ms. Os (Hong Kong) study

    Cohort studyOsteoporosis

  14. Osteoporos Int

    A systematic review and meta-analysis of sequential treatment strategies for osteoporosis

    Meta-analysisOsteoporosis

  15. Osteoporos Int

    Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis

    Cohort studyOsteoporosis

  16. Osteoporos Int

    Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study

    Cohort studyOsteoporosis

  17. Osteoporos Int

    A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis

    Randomized controlled trialOsteoporosis

  18. Osteoporos Int

    Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan

    Cohort studyOsteoporosis

  19. Osteoporos Int

    ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study

    Cohort studyOsteoporosis

  20. Osteoporos Int

    Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women’s Health

    Cohort studyOsteoporosis

  21. Osteoporos Int

    Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval

    Cohort studyOsteoporosis

  22. Osteoporos Int

    Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures

    Cohort studyOsteoporosis

  23. Osteoporos Int

    Impact of standard versus cyclic teriparatide and denosumab treatment on trabecular bone score: a post-hoc analysis of a randomized clinical trial

    Secondary analysisOsteoporosis

  24. Osteoporos Int

    Should we consider ankle fractures as osteoporotic fractures?

    Cross-sectional studyOsteoporosis

  25. Osteoporos Int

    Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis

    Case-control studyOsteoporosis

  26. Osteoporos Int

    Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry

    Cohort studyOsteoporosis

  27. Osteoporos Int

    The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans—a histomorphometry centered scoping review

    Research articleOsteoporosis

  28. Osteoporos Int

    Predictive capacity of fracture risk assessment tools: overview of systematic reviews

    Research articleOsteoporosis

  29. Osteoporos Int

    Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication

    Cohort studyOsteoporosis

  30. Osteoporos Int

    Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab

    Cohort studyOsteoporosis

  31. Osteoporos Int

    Latin American patients’ perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America

    Cross-sectional studyOsteoporosis

  32. Osteoporos Int

    The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose

    Cohort studyOsteoporosis

  33. Osteoporos Int

    Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) – emulation of a randomized target trial

    Cohort studyOsteoporosis

  34. Osteoporos Int

    Artificial intelligence system for predicting areal bone mineral density from plain X-rays

    Diagnostic or prognostic studyOsteoporosis

  35. Osteoporos Int

    Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures

    Cohort studyOsteoporosis

  36. Osteoporos Int

    More severe microdamage and micromechanical alterations: altered subchondral bone remodeling in varus knee osteoarthritis with osteoporosis

    Cross-sectional studyOsteoarthritis

  37. Osteoporos Int

    Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool

    Meta-analysisOsteoporosis

  38. Osteoporos Int

    Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  39. Osteoporos Int

    Increased all-cause mortality following proximal humerus fractures in Danish adults: a register-based matched cohort study of 93,952 fracture cases and 469,760 controls

    Cohort studyOsteoporosis

  40. Osteoporos Int

    Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation

    Guideline or statementOsteoporosis

All 576 Briefs in ExploreShowing Briefs 161–200 of 576, newest first